心之通路 治反有道 - 主动脉瓣纯反流专题讨论会
Seminar on Pure Aortic Regurgitation
04/19 15:30-17:30
杭州厅2&3 (Room Hangzhou 2&3)
-
15:30-17:30
-
15:30-17:30
-
15:30-17:30
-
15:30-15:40致辞Opening Remarks
-
15:40-15:55VitaFlow®应用于外科高危、严重主动脉瓣狭窄患者7年随访结果解读7-year Clinical Outcomes of MicroPort VitaFlow® Transcatheter Aortic Valve System in High Surgical Risk Patients with Severe Aortic Stenosis
-
15:55-16:00讨论Discussion
-
16:00-16:15《PAR 经股动脉TAVR中国专家共识2023》要点简介及基于PHASE原则的PAR TF-TAVR治疗Key Points from the 2023 Chinese Expert Consensus on TF-TAVR and Overview of PAR TF-TAVR Treatment Based on the PHASE Principle
-
16:15-16:20讨论Discussion
-
16:20-16:35应用VitaFlow Liberty®的主动脉瓣反流患者TAVR术后新发传导阻滞的预测因素Predictors for New-onset Conduction Block in Patients with Pure Aortic Regurgitation After TAVR with VitaFlow Liberty®
-
16:35-16:40讨论Discussion
-
16:40-16:55VitaFlow Liberty®纯反流病例应用经验分享Experience on Treating Pure AR Cases Using VitaFlow Liberty®
-
16:55-17:00讨论Discussion
-
17:00-17:15全新一代双层球囊扩张导管AccuSniperTM设计特点及实战病例Design Features and Challenging Case of AccuSniperTM, a New-generation Double-layer Balloon Expansion Catheter
-
17:15-17:20讨论Discussion
-
17:20-17:30总结Closing Remarks